Merrex Gold Inc (MXGIF) 0.1560 $MXGIF Merrex Gold -

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Merrex Gold Inc (MXGIF) 0.1560 $MXGIF

Merrex Gold - Karita Gold Project, Guinea Reconnaissance Exploration Team Reports Grab Samples to 19.40 g/t
ACCESSWIRE - Tue Jun 02, 8:35AM CDT
HALIFAX, NS / ACCESSWIRE / June 2, 2015 / Greg Isenor, President and CEO of Merrex Gold Inc., ("Merrex" or the "Company" (TSX Venture: MXI) announces:
MXI.VN: 0.190 (-0.015)

Merrex Gold - Oversubscribed Private Placement Closed
ACCESSWIRE - Wed May 13, 8:33AM CDT
HALIFAX, NS / ACCESSWIRE / May 13, 2015 / Greg Isenor, President and CEO of Merrex Gold Inc., ("Merrex" or the "Company" (TSX Venture: MXI) announces:
MXI.VN: 0.190 (-0.015)

Merrex Gold - Private Placement Increased to $621,200
ACCESSWIRE - Thu May 07, 10:01AM CDT
HALIFAX, NS / ACCESSWIRE / May 7 2015 / Greg Isenor, President and CEO of Merrex Gold Inc., ("Merrex" or the "Company" (TSX Venture: MXI) announces:
MXI.VN: 0.190 (-0.015)

Merrex Gold - Diakha Drilling Update, Karita Exploration Progress and Private Placement
ACCESSWIRE - Tue Apr 21, 8:35AM CDT
HALIFAX, NOVA SCOTIA / ACCESSWIRE / April 21, 2015 / Greg Isenor, President and CEO of Merrex Gold Inc., ("Merrex" or the "Company" (TSX Venture: MXI) is pleased to provide shareholders with the following update on the 2015 drilling program on the Diakha deposit area of the Siribaya Gold Project, West Mali, and exploration for the Karita Permit, Guinea:
MXI.VN: 0.190 (-0.015)

Merrex Gold - Private Placement
ACCESSWIRE - Tue Apr 14, 1:48PM CDT
HALIFAX, NS / ACCESSWIRE / April 14, 2015 / Greg Isenor, President and CEO of Merrex Gold Inc., ("Merrex" or the "Company" (TSX Venture: MXI) announces:
MXI.VN: 0.190 (-0.015)

Merrex Gold - Permit Renewal Update and Debt Settlement
ACCESSWIRE - Tue Apr 14, 11:54AM CDT
HALIFAX, NS / ACCESSWIRE / April 14, 2015 / Greg Isenor, President and CEO of Merrex Gold Inc., ("Merrex" or the "Company" (TSX Venture: MXI) announces:
MXI.VN: 0.190 (-0.015)

Merrex Gold - Diakha Drilling Update, Siribaya Gold Project
ACCESSWIRE - Tue Apr 07, 6:16PM CDT
HALIFAX, NS / ACCESSWIRE / April 7, 2015 / Greg Isenor, President and CEO of Merrex Gold Inc., ("Merrex" or the "Company" (TSX Venture: MXI) is pleased to provide shareholders with the following update on the 2015 drilling program on the Diakha deposit area of the Siribaya Gold Project, West Mali:
MXI.VN: 0.190 (-0.015)

Merrex Gold Shareholders Approve IAMGOLD as New Control Person; Reconnaissance Mapping and Sampling of Karita
ACCESSWIRE - Wed Apr 01, 6:15PM CDT
HALIFAX, NS / ACCESSWIRE / April 1, 2015 / Greg Isenor, President and CEO of Merrex Gold Inc., ("Merrex" or the "Company" (TSX Venture: MXI) is pleased to report on the results of the Annual General Meeting held March 26, 2015.
MXI.VN: 0.190 (-0.015)

Merrex Gold Granted Karita Permit, Guinea
ACCESSWIRE - Wed Mar 25, 9:57AM CDT
HALIFAX, NS / ACCESSWIRE / March 25, 2015 / Greg Isenor, President and CEO of Merrex Gold Inc., ("Merrex" or the "Company" (TSX Venture: MXI) is pleased to announce:
MXI.VN: 0.190 (-0.015)

Merrex Gold - Siribaya Gold Project Drilling Update
ACCESSWIRE - Mon Feb 09, 8:34AM CST
HALIFAX, NS / ACCESSWIRE / February 9, 2015 / Greg Isenor, President and CEO of Merrex Gold Inc., ("Merrex" or the "Company" (TSX Venture: MXI) is pleased to provide shareholders with the following drilling update:
MXI.VN: 0.190 (-0.015)

Merrex Gold - US$3.8 Million Drill Program for Diakha Commenced, Maiden Resource Estimate Planned by Year End
ACCESSWIRE - Mon Feb 02, 8:34AM CST
HALIFAX, NOVA SCOTIA / ACCESSWIRE / February 2, 2015 / Greg Isenor, President and CEO of Merrex Gold Inc., ("Merrex" or the "Company" (TSX Venture: MXI) is pleased to announce:
MXI.VN: 0.190 (-0.015)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Insights from the New First Presidency on Global Challenges

Updated Category News Views 218

A Historic Conversation with the First Presidency The recent interview featuring the new First Presidency of The Church of Jesus Christ of Latter-day Saints marks an exciting milestone. Conducted by the talented Jane Clayson Johnson, this unique dialogue sheds light on pressing issues within the Church and broader society. It was their first public discussion, making it a...

Continue Reading
Major Bets on Donald Trump's Election Surge Past $52 Million

Updated Category News Views 119

Significant Bets on Trump's Electoral Success A trader on Polymarket, operating under the alias Fredi9999, alongside four other accounts, has made headlines recently by placing enormous bets on Donald Trump’s electoral prospects. This activity has generated considerable chatter among traders in the market. Tracking Trump's Betting Activity Harry Crane, a statistics...

Continue Reading
FMC Corporation Faces Lawsuit Over Securities Violations

Updated Category News Views 190

FMC Corporation Faces Lawsuit Over Securities Violations Recently, the Gross Law Firm has alerted shareholders of FMC Corporation (NYSE: FMC) regarding significant legal developments. This lawsuit brings attention to serious allegations concerning the company's conduct during a specific class period. Shareholder Engagement and Participation Shareholders who purchased FMC...

Continue Reading
Insider Buying at Optima Health Signals Confidence in Future Growth

Updated Category News Views 132

Insightful Insider Share Purchase at Optima Health Optima Health plc (AIM: OPT), a leading provider of corporate health and wellbeing solutions in the UK, recently announced an important transaction involving one of its key insiders. Joanne Newey, who takes on the role of Group Business Development & Propositions Director and is also a Person Discharging Managerial...

Continue Reading
Outlook Therapeutics Prepares for Upcoming Investor Interaction

Updated Category News Views 78

Outlook Therapeutics Connects with Investors at Upcoming Virtual Event ISELIN, N.J. — Outlook Therapeutics, Inc. (Nasdaq: OTLK) has been making waves in the biopharmaceutical field with its groundbreaking ocular therapy. This marks an exciting era for the company following the recent approval of its eye treatment formulation of bevacizumab, which targets wet age-related...

Continue Reading